These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22512088)

  • 1. Carboxymethylcellulose sodium improves the pharmacodynamics of 1-deoxynojirimycin by changing its absorption characteristics and pharmacokinetics in rats.
    Wang L; Peng J; Wang X; Zhu X; Cheng B; Gao J; Jiang M; Bai G; Hou Y
    Pharmazie; 2012 Feb; 67(2):168-73. PubMed ID: 22512088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic mechanism of enhancement by Radix Pueraria flavonoids on the hyperglycemic effects of Cortex Mori extract in rats.
    Xiao BX; Wang Q; Fan LQ; Kong LT; Guo SR; Chang Q
    J Ethnopharmacol; 2014 Feb; 151(2):846-51. PubMed ID: 24333478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of orally administered mulberry 1-deoxynojirimycin in rat plasma.
    Nakagawa K; Kubota H; Kimura T; Yamashita S; Tsuzuki T; Oikawa S; Miyazawa T
    J Agric Food Chem; 2007 Oct; 55(22):8928-33. PubMed ID: 17914870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 1-deoxynojirimycin and aqueous mulberry leaf extract with emphasis on postprandial hypoglycemic effects: in vivo and in vitro studies.
    Kwon HJ; Chung JY; Kim JY; Kwon O
    J Agric Food Chem; 2011 Apr; 59(7):3014-9. PubMed ID: 21370820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of absorption of 1-deoxynojirimycin from mulberry water extract in rats.
    Kim JY; Kwon HJ; Jung JY; Kwon HY; Baek JG; Kim YS; Kwon O
    J Agric Food Chem; 2010 Jun; 58(11):6666-71. PubMed ID: 20450200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiobesity effects and improvement of insulin sensitivity by 1-deoxynojirimycin in animal models.
    Kong WH; Oh SH; Ahn YR; Kim KW; Kim JH; Seo SW
    J Agric Food Chem; 2008 Apr; 56(8):2613-9. PubMed ID: 18363357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary 5,6,7-Trihydroxy-flavonoid Aglycones and 1-Deoxynojirimycin Synergistically Inhibit the Recombinant Maltase-Glucoamylase Subunit of α-Glucosidase and Lower Postprandial Blood Glucose.
    Dong YS; Yu N; Li X; Zhang B; Xing Y; Zhuang C; Xiu ZL
    J Agric Food Chem; 2020 Aug; 68(33):8774-8787. PubMed ID: 32806121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Deoxynojirimycin and its Derivatives: A Mini Review of the Literature.
    Wang H; Shen Y; Zhao L; Ye Y
    Curr Med Chem; 2021; 28(3):628-643. PubMed ID: 31942844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the anti-hyperglycemic effect and safety of microorganism 1-deoxynojirimycin.
    Takasu S; Parida IS; Onose S; Ito J; Ikeda R; Yamagishi K; Higuchi O; Tanaka F; Kimura T; Miyazawa T; Nakagawa K
    PLoS One; 2018; 13(6):e0199057. PubMed ID: 29897983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-deoxynojirimycin inhibits glucose absorption and accelerates glucose metabolism in streptozotocin-induced diabetic mice.
    Li YG; Ji DF; Zhong S; Lin TB; Lv ZQ; Hu GY; Wang X
    Sci Rep; 2013; 3():1377. PubMed ID: 23536174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of α-glucosidase activity by N-deoxynojirimycin analogs in several insect phloem sap feeders.
    Ya'kobovitz MK; Butters TD; Cohen E
    Insect Sci; 2016 Feb; 23(1):59-67. PubMed ID: 25900765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1-Deoxynojirimycin on insulin resistance in prediabetic mice based on next-generation sequencing and intestinal microbiota study.
    Ren X; Xing Y; He L; Xiu Z; Yang L; Han A; Jia Q; Dong Y
    J Ethnopharmacol; 2022 May; 289():115029. PubMed ID: 35077826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intake of 1-deoxynojirimycin suppresses lipid accumulation through activation of the beta-oxidation system in rat liver.
    Tsuduki T; Nakamura Y; Honma T; Nakagawa K; Kimura T; Ikeda I; Miyazawa T
    J Agric Food Chem; 2009 Nov; 57(22):11024-9. PubMed ID: 19863049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between 1-deoxynojirimycin content and alpha-glucosidase inhibitory activity in leaves of 276 mulberry cultivars (Morus spp.) in Kyoto, Japan.
    Yatsunami K; Ichida M; Onodera S
    J Nat Med; 2008 Jan; 62(1):63-6. PubMed ID: 18404344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans.
    Kimura T; Nakagawa K; Kubota H; Kojima Y; Goto Y; Yamagishi K; Oita S; Oikawa S; Miyazawa T
    J Agric Food Chem; 2007 Jul; 55(14):5869-74. PubMed ID: 17555327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological Effects and Organ Distribution of Bacillus amyloliquefaciens AS385 Culture Broth Powder Containing 1-Deoxynojirimycin in C57BL/6J Mice.
    Parida IS; Takasu S; Ito J; Ikeda R; Yamagishi K; Kimura T; Miyazawa T; Eitsuka T; Nakagawa K
    J Nutr Sci Vitaminol (Tokyo); 2019; 65(2):157-163. PubMed ID: 31061284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel gelatin crosslinking method retards release of mulberry 1-deoxynojirimycin providing a prolonged hypoglycaemic effect.
    Vichasilp C; Nakagawa K; Sookwong P; Higuchi O; Kimura F; Miyazawa T
    Food Chem; 2012 Oct; 134(4):1823-30. PubMed ID: 23442626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of therapeutic potential of N-alkylated 1-deoxynojirimycin congeners.
    Iftikhar M; Lu Y; Zhou M
    Carbohydr Res; 2021 Jun; 504():108317. PubMed ID: 33932806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal Absorption and Tissue Distribution of Aza-Sugars from Mulberry Leaves and Evaluation of Their Transport by Sugar Transporters.
    Takasu S; Parida IS; Ito J; Kojima Y; Eitsuka T; Kimura T; Nakagawa K
    J Agric Food Chem; 2020 Jun; 68(24):6656-6663. PubMed ID: 32449853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of oral bioadhesive controlled release formulations of miglitol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels.
    Deshpande MC; Venkateswarlu V; Babu RK; Trivedi RK
    Int J Pharm; 2009 Oct; 380(1-2):16-24. PubMed ID: 19563873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.